TAFAZZIN and Barth syndrome: The major pathognomonic metabolic abnormality in BTHS is the elevation of the monolysocardiolipin (MLCL) to cardiolipin (CL) ratio [7,8,9,10,11], ushering the critical function of TAZ in CL remodeling.